UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): SEPTEMBER 28, 2004
UGI CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
PENNSYLVANIA 1-11071 23-2668356
(STATE OR OTHER JURISDICTION (COMMISSION FILE (I.R.S. EMPLOYER
OF INCORPORATION) NUMBER) IDENTIFICATION NO.)
460 N. GULPH ROAD
KING OF PRUSSIA, PENNSYLVANIA 19406
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
(610) 337-1000
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
CHECK THE APPROPRIATE BOX BELOW IF THE FORM 8-K FILING IS INTENDED TO
SIMULTANEOUSLY SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE
FOLLOWING PROVISIONS (SEE GENERAL INSTRUCTION A.2. BELOW):
[ ] WRITTEN COMMUNICATIONS PURSUANT TO RULE 425 UNDER THE SECURITIES ACT (17
CFR 230.425)
[ ] SOLICITING MATERIAL PURSUANT TO RULE 14a-12 UNDER THE EXCHANGE ACT (17
CFR 240.14a-12)
[ ] PRE-COMMENCEMENT COMMUNICATIONS PURSUANT TO RULE 14d-2(b) UNDER THE
EXCHANGE ACT (17 CFR 240.14d-2(b))
[ ] PRE-COMMENCEMENT COMMUNICATIONS PURSUANT TO RULE 13e-4(c) UNDER THE
EXCHANGE ACT (17 CFR 240.13e-4(c))
UGI Corporation Form 8-K
Page 2 September 28, 2004
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN
FISCAL YEAR.
At the 2004 Annual Meeting of Shareholders of UGI Corporation, holders of
a majority of the outstanding shares approved the following shareholder
proposal:
"Shareholder Opportunity to Vote Regarding a Poison Pill
Shareholders recommend a bylaw subjecting to a shareholder vote, the
adoption or extension of any current or future poison pill."
Following careful consideration of this matter, on September 28, 2004, the Board
of Directors of UGI Corporation voted unanimously to adopt a new bylaw. The new
bylaw provides as follows:
SECTION 4.13. ADOPTION OR EXTENSION OF SHAREHOLDER RIGHTS PLAN. The board
of directors shall not adopt or extend any current or future shareholder
rights plan, or "poison pill," without prior shareholder approval unless
the board, in discharging its fiduciary duties, and acting upon the
recommendation of the non-management directors, determines that such
adoption or extension would be in the best interests of the corporation
under the circumstances. If any shareholder rights plan is adopted or
extended without prior shareholder approval, it shall be presented to
shareholders for approval within one year or expire within one year
without being renewed or replaced.
The bylaws of UGI Corporation, as amended through September 28, 2004, are filed
as Exhibit 3.2 to this Current Report on Form 8-K.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
3.2 Bylaws of UGI Corporation as amended through September 28,
2004.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d), the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
UGI CORPORATION
(REGISTRANT)
By: /s/ Margaret M. Calabrese
--------------------------------
Margaret M. Calabrese
Secretary
Date: September 30, 2004
EXHIBIT INDEX
The following exhibit is filed as part of this Report:
EXHIBIT NO. DESCRIPTION
3.2 Bylaws of UGI Corporation as amended through
September 28, 2004